Helping cancer patients afford to participate in clinical trials

Plus: Does health care price regulation really work? 

August 30, 2024 Check out STAT+

Sponsored By

Adobe Opinion: The importance of reducing the financial burden of participating in clinical trials Some clinical trial sponsors are reluctant to provide financial support because of the current legal landscape. Congress can fix it. By Jim Murphy and Lisa Lacasse Opinion: Health care price regulation is undemocratic Eventually, governments setting prices leads to unintended negative consequences, creating a net negative for patients and society. By Ge Bai Opinion: STAT readers on mask bans, cancer screening, and empathy and AI The executive director of the American Lung Cancer Screening initiative fires back at a recent First Opinion essay. By Torie Bosch

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser